Earnings Alerts

Jiangsu Hengli Highpressure Oil Cylinder (601100) Earnings Surpass Expectations with Strong 3Q Performance

By October 27, 2025 No Comments
  • Jiangsu Hengli reported a strong financial performance in the third quarter of 2025, surpassing market expectations.
  • The company achieved a net income of 657.7 million yuan. Analysts had estimated a significant loss of approximately 8.98 billion yuan.
  • Jiangsu Hengli’s revenue for the quarter was 2.62 billion yuan, slightly above the projected revenue of 2.61 billion yuan.
  • Market sentiment appears positive towards Jiangsu Hengli, with 32 buy recommendations, 3 hold recommendations, and just 1 sell recommendation from analysts.

A look at Jiangsu Hengli Highpressure Oil Cylinder Smart Scores

FactorScoreMagnitude
Value2
Dividend3
Growth4
Resilience5
Momentum5
OVERALL SMART SCORE3.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Investors looking at Jiangsu Hengli Highpressure Oil Cylinder‘s long-term prospects may find optimism in its Smartkarma Smart Scores. The company scored high in Growth, Resilience, and Momentum, indicating positive indicators for its future performance. These scores suggest that Jiangsu Hengli Highpressure Oil Cylinder is well-positioned to benefit from growth opportunities, demonstrate resilience in the face of challenges, and maintain positive momentum in the market.

Jiangsu Hengli Highpressure Oil Cylinder, a subsidiary of Jiangsu Hengli Hydraulic Co Ltd, specializes in developing, manufacturing, and selling high-pressure tanks, hydraulic components, and systems. With a focus on fuel tanks and non-standard cylinders for heavy equipment, the company plays a crucial role in the industrial sector, providing essential products for heavy machinery applications.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars